Table 3B. Univariate and multivariate Cox proportional hazard analyses of clinicopathologic variables for disease-specific survival rate.
| |
|
Univariate analysis |
Multivariate analysis |
||||
|---|---|---|---|---|---|---|---|
| Variable | HR | 95% Confidence interval | P-value | HR | 95% Confidence interval | P-value | |
| Age |
>50 vs ⩽50 years |
1.095 |
0.645–1.857 |
0.738 |
0.876 |
0.487–1.574 |
0.657 |
| Sex |
Male vs female |
3.04 |
0.421–21.953 |
0.27 |
2.077 |
0.276–15.610 |
0.478 |
| Stage |
III/IV vs I/II |
5.624 |
3.090–10.237 |
<0.001* |
4.105 |
2.034–8.287 |
<0.001* |
| Histologic grade |
G3 vs G1/G2 |
1.415 |
0.696–2.877 |
0.338 |
1.115 |
0.479–2.598 |
0.801 |
| Lymphovascular invasion |
Present vs absent |
4.641 |
2.780–7.748 |
<0.001* |
2.119 |
1.177–3.818 |
0.012* |
| Necrosis |
Extensive vs limited/no |
1.651 |
0.967–2.820 |
0.066 |
0.884 |
0.457–1.709 |
0.714 |
| LC3B expression |
High vs low |
1.711 |
1.033–2.833 |
0.035* |
1.253 |
0.727–2.158 |
0.417 |
| p62 cytoplasmic expression |
High vs low |
2.298 |
1.368–3.862 |
0.001* |
1.736 |
0.980–3.076 |
0.059 |
| p62 nuclear expression | Low vs high | 2.545 | 1.414–4.579 | 0.002* | 2.571 | 1.356–4.874 | 0.004* |
Abbreviation: HR=hazard ratio